We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-13.3%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$580M
AUM Growth
-$257M
(-31%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-23.05%
Top 10 Holdings %
Top 10 Hldgs %
37.84%
Holding
94
New
2
Increased
24
Reduced
33
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
+$13.2M |
| 2 |
Inspire Medical Systems
INSP
|
+$9.36M |
| 3 |
iRhythm Holdings
IRTC
|
+$7.84M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$7.22M |
| 5 |
Tandem Diabetes Care
TNDM
|
+$7.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
+$36.8M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$17.3M |
| 3 |
APLS
Apellis Pharmaceuticals
APLS
|
+$13.6M |
| 4 |
AGN
Allergan plc
AGN
|
+$12M |
| 5 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.54% |
| 2 | Industrials | 3.13% |
| 3 | Technology | 2.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Teladoc Health
TDOC
$1.71B
| $35.6M | 6.14% |
525,511
+12,345
| +2% | +$812K |
|
|
FOLD
2
DELISTED
Amicus Therapeutics
FOLD
| $27.6M | 4.76% |
3,441,922
+117,299
| +4% | +$1.27M |
|
|
3
Tandem Diabetes Care
TNDM
$1.23B
| $25.5M | 4.4% |
432,815
+112,949
| +35% | +$7.21M |
|
|
APLS
4
DELISTED
Apellis Pharmaceuticals
APLS
| $24M | 4.14% |
996,983
-492,974
| -33% | -$13.6M |
|
|
WMGI
5
DELISTED
Wright Medical Group Inc
WMGI
| $21.9M | 3.79% |
1,063,872
+552,699
| +108% | +$13.2M |
|
|
AERI
6
DELISTED
Aerie Pharmaceuticals
AERI
| $21M | 3.62% |
1,091,534
+135,498
| +14% | +$3.1M |
|
|
SWAV
7
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $17.2M | 2.96% |
573,434
-276,377
| -33% | -$11.7M |
|
|
8
Inspire Medical Systems
INSP
$1.52B
| $16.1M | 2.77% |
263,100
+142,200
| +118% | +$9.36M |
|
9
Gilead Sciences
GILD
$165B
| $15.7M | 2.7% |
246,940
-151,100
| -38% | -$9.88M |
|
|
10
Alnylam Pharmaceuticals
ALNY
$36.4B
| $14.8M | 2.56% |
184,341
-218,300
| -54% | -$17.3M |
|
|
PTLA
11
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $14.7M | 2.53% |
546,489
-175,067
| -24% | -$4.91M |
|
12
Bristol-Myers Squibb
BMY
$124B
| $14.2M | 2.45% |
280,597
+65,900
| +31% | +$3.1M |
|
|
13
iRhythm Holdings
IRTC
$3.71B
| $13.9M | 2.4% |
187,750
+101,150
| +117% | +$7.84M |
|
14
Novartis
NVS
$288B
| $12.8M | 2.22% |
147,846
-34,800
| -19% | -$3.12M |
|
15
PTC Therapeutics
PTCT
$6.48B
| $12.8M | 2.2% |
377,238
-73,400
| -16% | -$3.19M |
|
|
KYNB
16
Kyntra Bio
KYNB
$29M
| $12.3M | 2.13% |
13,338
+1,232
| +10% | +$1.35M |
|
|
IMMU
17
DELISTED
Immunomedics Inc
IMMU
| $12.1M | 2.08% |
909,822
+490,922
| +117% | +$7.22M |
|
|
VCRA
18
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $11.8M | 2.04% |
478,728
+97,124
| +25% | +$2.52M |
|
|
GBT
19
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $11.7M | 2.02% |
241,040
+14,799
| +7% | +$771K |
|
20
Evolent Health
EVH
$651M
| $11.4M | 1.97% |
1,585,752
+227,400
| +17% | +$1.63M |
|
21
AtriCure
ATRC
$1.79B
| $11.2M | 1.93% |
447,455
+60,231
| +16% | +$1.72M |
|
|
RARX
22
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $10.7M | 1.84% |
451,247
-214,466
| -32% | -$6.36M |
|
23
Collegium Pharmaceutical
COLL
$1.15B
| $10.4M | 1.79% |
905,247
-269,600
| -23% | -$3.08M |
|
|
LJPC
24
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $10.2M | 1.76% |
1,158,271
-498,900
| -30% | -$4.71M |
|
25
Merck
MRK
$309B
| $9.9M | 1.71% |
123,245
-51,561
| -29% | -$4.13M |
|
Similar funds
RIP
CCM
LFWA
FWA
CF
WIM
MW
AFC
Sectoral Asset Management's Q3 2019 Portfolio in Review
As of Q3 2019, Sectoral Asset Management held 94 positions worth $580M, down 31% from $836M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Sectoral Asset Management withdrew a net $134M in Q3 2019, closing 31 positions and reducing 33 holdings. Its most notable exit was Array Biopharma Inc, an estimated $36.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 84% of assets, down from 85% a quarter earlier, followed by Industrials and Technology.
Against the trend, Sectoral Asset Management opened a new position in Tabula Rasa HealthCare, Inc. Common Stock worth $6.63M.
- Sectoral Asset Management's largest Q3 2019 buy was Tabula Rasa HealthCare, Inc. Common Stock: 120,600 shares worth $6.63M.
- Sectoral Asset Management added most to Wright Medical Group Inc in Q3 2019, an estimated $13.2M increase.
- Sectoral Asset Management's biggest Q3 2019 reduction was Alnylam Pharmaceuticals, cutting an estimated $17.3M.
- Sectoral Asset Management fully exited Array Biopharma Inc in Q3 2019, selling an estimated $36.8M.
- Sectoral Asset Management's ten largest holdings make up 38% of its $580M portfolio in Q3 2019.
- Sectoral Asset Management opened 2 new positions and closed 31 in Q3 2019.
- Sectoral Asset Management's portfolio value fell 31% quarter-over-quarter to $580M.
Based on Sectoral Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.